United States · Funded startup

Who invested in Pear Therapeutics

4 rounds we have observed, with the 13 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$239Mraised across 4 rounds since 2015, from 4 sources

$50MSeries B$64MSeries C$125MRound
Latest round
Round, $125MDec 2021
Step-upi
2×
Investors
13
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2015201620172018201920202021
?Venture$50MSeries B$64MSeries C$125MRound
First round
Venture
Mar 2015
Biggest round
$125M
Round · Dec 2021
Usual gap between rounds
22 months
the median of 3

The rounds

  1. Dec 2021
  2. Jan 2018
    Series C$64M2 new4 returning

    Reported by BusinesswireSEC filing: $46M sold, first sale Dec 2017

  3. Jan 2017
  4. Mar 2015
    VentureAmount undisclosed1 new

    From a historical funding record

Founders and team

From the SEC filings it signed: 7 on the team.

  • Christopher GuiffreExecutive Officeri
  • Corey McCannExecutive Officer, Directori
  • Elena VibochMs. Viboch was elected as a Director subsequent to the Date of First Sale.i
  • Julia StrandbergExecutive Officeri
  • Nancy SchlichtingMs. Schlichting was elected as a Director subsequent to the Date of First Sale.i
  • Ronan O'BrienExecutive Officeri
  • Yuri MaricichExecutive Officeri

On the board, as filediAndrew SchwabTimothy PetersenZack Lynch

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

5AM VenturesVC firm3rounds
EDBIVC firm2rounds
NovartisVC firm2rounds
Arboretum VenturesVC firm2rounds
Jazz Venture PartnersVC firm2rounds
Temasek HoldingsVC firm1round
SoftBankInvestment firm1round
Perceptive AdvisorsAsset manager1round
Temasek/ 5AMno record of our own yet1round
Temasek/ Novartisno record of our own yet1round
The Bridge Builders Collaborativeno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Pear Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

For Good VenturesVC firmPer its own site

Quick answers about Pear Therapeutics

Who invested in Pear Therapeutics?

Pear Therapeutics's investors include 5AM Ventures, EDBI, Novartis, Arboretum Ventures and Jazz Venture Partners, and 8 more on record.

How much has Pear Therapeutics raised?

Pear Therapeutics has raised $239M across 4 rounds since 2015. One round did not disclose an amount, so the total is a floor.

When did Pear Therapeutics last raise?

Pear Therapeutics's most recent round was an Undisclosed round of $125M in Dec 2021.

What was Pear Therapeutics's biggest round?

Its most recent round, $125M in Dec 2021, is also its largest on record.

Who backed Pear Therapeutics first?

Pear Therapeutics's first round on record, in Mar 2015, was backed by 5AM Ventures.

What stage is Pear Therapeutics at?

Pear Therapeutics's latest named round is an Undisclosed round, in Dec 2021.

Where is Pear Therapeutics based?

Pear Therapeutics is based in the United States.

Companies like Pear Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.